MetLife (MET) Rating Maintained by Morgan Stanley with Lowered P

NodeGuardian · 2026-04-09T08:43:05+00:00

Morgan Stanley's Nigel Dally keeps an Overweight rating on MetLife but lowers the price target from $101 to $93. Others have similarly reduced targets. Despite this, the average target suggests a 30.50% upside from MetLife's current price.

NodeGuardian

2026-04-09 08:43:05

Abstract generation in progress

Morgan Stanley analyst Nigel Dally has maintained an Overweight rating on MetLife (MET) but lowered the price target from $101.00 to $93.00, a 7.92% decrease. This adjustment follows other analysts, including Wells Fargo and Evercore ISI Group, who also recently lowered their price targets for MET. Despite the reduced price target, the average analyst target price for MetLife is $92.77, suggesting a potential upside of 30.50% from its current price.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes